taxonomy (4)
protein (9)
source (5)
structure (2)
composition (1)
disease (2)
reference (6)
site (25)
peptide (81)
- Homo sapiens (Human)
- Mus musculus (House mouse)
- Rattus norvegicus (Norway rat)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- 4F2 cell-surface antigen heavy chain / Homo sapiens P08195
- Intercellular adhesion molecule-3 (CD50) / Homo sapiens P32942
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens P11279
- Sodium/potassium-transporting ATPase subunit beta-1 / Homo sapiens P05026
- Lysosome-associated membrane glycoprotein 1 / Mus musculus P11438
- Uncharacterized protein from Undefined tissue / Rattus norvegicus
- Uncharacterized protein from Undefined tissue / Rattus norvegicus
- Uncharacterized protein from Undefined tissue / Rattus norvegicus
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Brain (UBERON_0000955)
- Mammary Gland (UBERON_0001911)
- 3Y1-B clone 1 (CVCL_4563)
- HEK293 (CVCL_0045)
- T-Lymphocyte (CL_0000084)
Source
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x Gal(b1-4)GlcNAc(b1-3)"
Reported structure
- Hex:10 HexNAc:9 (avg mass : 3468.1943 )
Composition
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Structural study of N-linked oligosaccharides of human intercellular adhesion molecule-3 (CD50). (2001 - Funatsu O, Sato T, Kotovuori P, Gahmberg CG, Ikekita M, Furukawa K) / Status : Reviewed
- Transfection with fragments of the adenovirus 12 gene induces tumorigenicity-associated alteration of N-linked sugar chains in rat cells. (1990 - Hiraizumi S, Takasaki S, Shiroki K, Kochibe N, Kobata A) / Status : Reviewed
Reference
- 4F2 cell-surface antigen heavy chain / Homo sapiens
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Sodium/potassium-transporting ATPase subunit beta-1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Mus musculus
-
Uncharacterized protein from Undefined tissue / Rattus norvegicus
- Undefined site
-
Uncharacterized protein from Undefined tissue / Rattus norvegicus
- Undefined site
-
Uncharacterized protein from Undefined tissue / Rattus norvegicus
- Undefined site
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- PFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEK (41aa)
- HVSGTNGTKR (10aa)
- FHAIHVSGTNGTK (13aa)
- VTWFHAIHVSGTNGTKR (17aa)
- ENVSDPSLTITFGR (14aa)
- NATNVVIK (8aa)
- TQSLLIVNNATNVVIKVCEFQFCNDPFL (28aa)
- LLIVNNATNVVIK (13aa)
- SNIIRGWIFGTTLDSKTQSLLIVNN (25aa)
- SNIIRGWIFGTTLDSKTQSLLIVNNATNVVIK (32aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPF (28aa)
- NNKSWMESEFRVYSSANNCTF (21aa)
- NNKSWMESEFRVYSSANNCTFEYVS (25aa)
- NNKSWMESEFRVYSSANNCTFEYVS (25aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFLM (30aa)
- NNKSWMESEFRVYSSANNC (19aa)
- NNKSWMESEFRVYSSANNC (19aa)
- NNKSWMESEFRVYSSANNCTFEYVSQ (26aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGK (35aa)
- NNKSWMESEFRVYSSANNCT (20aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFL (29aa)
- NNKSWMESEFRVYSSANNCTFEY (23aa)
- NNKSWMESEFRVYSSANN (18aa)
- NNKSWM (6aa)
- NNKSWMESE (9aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFLMD (31aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFEYVSQPFLMDL (21aa)
- SWMESEFRVYSSANNCTFEYVSQP (24aa)
- INITR (5aa)
- IININPNK (8aa)
- YIQPIIAVQFTNITMDTEIR (20aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCAL (15aa)
- PTESIVRFPNITNLCPFGEVFNATR (25aa)
- NITNLCPFGEVFNATR (16aa)
- FPNITNLCPFGEVFN (15aa)
- PNITNLCPFGEVFNATR (17aa)
- FPNITNLCPFG (11aa)
- VQPTESIVRFPNITNLCPFGEVFNAT (26aa)
- FPNITNLCPFGEVFNATRFASVYAWNR (27aa)
- IIIAGTNSSDIQQIISIIESNK (22aa)
- NTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (32aa)
- DIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVN (49aa)
- DPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPV (45aa)
- DPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (57aa)
- GTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (34aa)
- VYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASY (40aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEI (35aa)
- NNSIAIPTNFTISVTTEILPVSMTK (25aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMT (41aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFT (28aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNF (28aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTI (29aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTT (34aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNF (27aa)
- NSVAYSNNSIAIPTNFTISVTTEILPVSMTK (31aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTI (30aa)
- YTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTK (39aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILP (37aa)
- DFGGFNFSQILPDP (14aa)
- KDFGGFNFSQILPDPSK (17aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQ (51aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDNTFVS (32aa)
- SNGTHWFVTQR (11aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- NHTSPDVDLGDISGINASVV (20aa)
- YFKNHTSPDVDLGDISGINASVVN (24aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- NHTSPDVDLGDISGINASVVNI (22aa)
- YFKNHTSPDVDLGDISGINAS (21aa)
- YFKNHTSPDVDLGDISGINAS (21aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- YFKNHTSPDVDLGDISGINASVVNI (25aa)
- YFKNHTSPDVDLGDISGINASVVNI (25aa)
- NHTSPDVDLGDISGINASVVNIQ (23aa)
- YFKNHTSPDVDLGDISGINA (20aa)
- LDKYFKNHTSPDVDLGDISGINASVVNIQK (30aa)
- YFKNHTSPDVDLGDISGIN (19aa)
- EELDKYFKNHTSPDVDLGDISGINASV (27aa)
- NHTSPDVDLGDISGIN (16aa)
- NHTSPDVDLGDISGIN (16aa)
- NHTSPDVDLGDISGINASVVN (21aa)
- NHTSPDVDLGDISGINASV (19aa)
- INASVVNIQK (10aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex (avg mass : 3468.1943)
- 3Y1-B clone 1 (CVCL_4563)
-
Uncharacterized protein from Undefined tissue / Rattus norvegicus
- Undefined site
-
Uncharacterized protein from Undefined tissue / Rattus norvegicus
- Undefined site
-
Uncharacterized protein from Undefined tissue / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex (avg mass : 3468.1943)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- Hex:10 HexNAc:9 / N-Linked (avg mass : 3468.1943)
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x Gal(b1-4)GlcNAc(b1-3)"
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Sodium/potassium-transporting ATPase subunit beta-1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Mus musculus
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- PFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEK (41aa)
- HVSGTNGTKR (10aa)
- FHAIHVSGTNGTK (13aa)
- VTWFHAIHVSGTNGTKR (17aa)
- ENVSDPSLTITFGR (14aa)
- NATNVVIK (8aa)
- TQSLLIVNNATNVVIKVCEFQFCNDPFL (28aa)
- LLIVNNATNVVIK (13aa)
- SNIIRGWIFGTTLDSKTQSLLIVNN (25aa)
- SNIIRGWIFGTTLDSKTQSLLIVNNATNVVIK (32aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPF (28aa)
- NNKSWMESEFRVYSSANNCTF (21aa)
- NNKSWMESEFRVYSSANNCTFEYVS (25aa)
- NNKSWMESEFRVYSSANNCTFEYVS (25aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFLM (30aa)
- NNKSWMESEFRVYSSANNC (19aa)
- NNKSWMESEFRVYSSANNC (19aa)
- NNKSWMESEFRVYSSANNCTFEYVSQ (26aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGK (35aa)
- NNKSWMESEFRVYSSANNCT (20aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFL (29aa)
- NNKSWMESEFRVYSSANNCTFEY (23aa)
- NNKSWMESEFRVYSSANN (18aa)
- NNKSWM (6aa)
- NNKSWMESE (9aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFLMD (31aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFEYVSQPFLMDL (21aa)
- SWMESEFRVYSSANNCTFEYVSQP (24aa)
- INITR (5aa)
- IININPNK (8aa)
- YIQPIIAVQFTNITMDTEIR (20aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCAL (15aa)
- PTESIVRFPNITNLCPFGEVFNATR (25aa)
- NITNLCPFGEVFNATR (16aa)
- FPNITNLCPFGEVFN (15aa)
- PNITNLCPFGEVFNATR (17aa)
- FPNITNLCPFG (11aa)
- VQPTESIVRFPNITNLCPFGEVFNAT (26aa)
- FPNITNLCPFGEVFNATRFASVYAWNR (27aa)
- IIIAGTNSSDIQQIISIIESNK (22aa)
- NTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (32aa)
- DIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVN (49aa)
- DPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPV (45aa)
- DPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (57aa)
- GTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (34aa)
- VYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASY (40aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEI (35aa)
- NNSIAIPTNFTISVTTEILPVSMTK (25aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMT (41aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFT (28aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNF (28aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTI (29aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTT (34aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNF (27aa)
- NSVAYSNNSIAIPTNFTISVTTEILPVSMTK (31aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTI (30aa)
- YTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTK (39aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILP (37aa)
- DFGGFNFSQILPDP (14aa)
- KDFGGFNFSQILPDPSK (17aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQ (51aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDNTFVS (32aa)
- SNGTHWFVTQR (11aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- NHTSPDVDLGDISGINASVV (20aa)
- YFKNHTSPDVDLGDISGINASVVN (24aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- NHTSPDVDLGDISGINASVVNI (22aa)
- YFKNHTSPDVDLGDISGINAS (21aa)
- YFKNHTSPDVDLGDISGINAS (21aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- YFKNHTSPDVDLGDISGINASVVNI (25aa)
- YFKNHTSPDVDLGDISGINASVVNI (25aa)
- NHTSPDVDLGDISGINASVVNIQ (23aa)
- YFKNHTSPDVDLGDISGINA (20aa)
- LDKYFKNHTSPDVDLGDISGINASVVNIQK (30aa)
- YFKNHTSPDVDLGDISGIN (19aa)
- EELDKYFKNHTSPDVDLGDISGINASV (27aa)
- NHTSPDVDLGDISGIN (16aa)
- NHTSPDVDLGDISGIN (16aa)
- NHTSPDVDLGDISGINASVVN (21aa)
- NHTSPDVDLGDISGINASV (19aa)
- INASVVNIQK (10aa)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
